The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII). AstraZeneca has reached a $750m agreement with […]
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen […]
Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort. The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which […]
The NIHR and UK Research and Innovation (UKRI) have awarded £10.5 million of funding to six new research projects on developing and testing vaccines and therapies for the novel coronavirus (COVID-19). One of the projects will investigate potential vaccines and could begin as early as June. Another of the funded projects will develop manufacturing processes to […]
Analysis of antipsychotic drugs could improve outcomes for schizophrenia patients Results of a new study published in The Lancet this month will help doctors to balance the benefits and side-effects of medication they prescribe to treat schizophrenia. Schizophrenia is one of the most common psychiatric disorders in adults worldwide – one in 100 people globally […]
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic […]
Oxford Brain Diagnostics, a spinout from Oxford University, has been launched to deliver a new method for diagnosing Alzheimer’s Disease from MRI scans. © Shutterstock The company is already engaged with pharmaceutical and biotech companies to help support them to accelerate the development of effective new drugs and treatments for Alzheimer’s Disease. The company will […]
A scheme that pays hospitals to deliver high quality care has been shown to improve the outcomes for patients with broken hips in England. © Shutterstock Hip fractures are a major cause of death and disability among older people worldwide, with 70,000 cases every year in the UK, which cost the NHS around £2 billion. […]